Patented use of EN2 protein as a diagnostic biomarker licensed to ZEUS Scientific
The University of Surrey in the UK and ZEUS Scientific, a US based global in vitro diagnostics company, announced today that they have entered into an agreement that grants ZEUS Scientific a worldwide non-exclusive license covering the development and commercialization of products utilizing ELISA and ZEUS’ multiplex technology platforms using the Engrailed-2 (EN2) protein as […]
